	Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations. Hepatol Commun Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB. PMID: 42319131 [PubMed - indexed for MEDLINE]
	Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates. Liver Int Korotych O, Thygesen HH, Mårdh O, Reyes-Urueña J, Marrone G, Rockstroh J, Jakobsen ML, de Martel C, Kondili LA, Quaranta MG, Mattioli B, Rosato S, Rendina M, De Feudis A, Cossiga V, Albano S, Morisco F, Viganò M, Loglio A, Fagiuoli S, Calvaruso V, Celsa C, Longobardi F, Coppola R, Russo FP, Battistella S, Coppola N, Sagnelli C, Coco B, Brunetto MR, Popovici O, Jan, Calomfirescu C, Gheorghe LS, Ghioca M, Ester C, Chitul M, Cerban R, Trifan A, Huiban L, Muzica C, Popescu A, Sirli R, Nica C, Popa A, Ferret MB, Vargas-Accarino E, Díaz A, Méndez CF, Morano L, Alonso S, Ahumada A, Cañizares RB, Raben D, Duffell E. PMID: 42318820 [PubMed - indexed for MEDLINE]
	Case Report: Multimodal management of duodenal metastasis from hepatocellular carcinoma complicated by intractable hemorrhage. Front Immunol Zhang X, Gao Z, Wang J, Xu B, Li B, Feng B, Jia K. PMID: 42317325 [PubMed - indexed for MEDLINE]
	Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma. Cancer Med Yang N, Wang T, Qian X, Li Z, Wang H, Xing H, Xu Y, Ma S, Meng B, Zhang X, Han F, Li Y, Li D, Zhuang H. PMID: 42316575 [PubMed - indexed for MEDLINE]
	Evaluation of metabolite biomarker candidates in detecting HCC in patients with liver cirrhosis. Metabolomics Rashid MM, Varghese RS, Sajid MS, Sherif ZA, Kroemer A, Ressom HW. PMID: 42315713 [PubMed - indexed for MEDLINE]
	Expanding hepatocellular carcinoma surveillance strategies in high-risk patients in Switzerland: a cost-effectiveness analysis. Swiss Med Wkly Goossens N, Garay OU, Wolf C, Ambüehl LE, Kugler V, Girardin FR. PMID: 42312979 [PubMed - indexed for MEDLINE]
	Primary hepatic gastrinoma as a clinical mimic: Favorable clinical outcomes. Endocrinol Diabetes Nutr (Engl Ed) Sanchis-Pascual D, de Miguel-Rodríguez L, Morillas-Amat P, Hernando J, García-Álvarez A, Landolfi S, Guerrero-Pérez F, Del Olmo-García MI, Capdevila J. PMID: 42309574 [PubMed - indexed for MEDLINE]
	Exploring fibronodular hepatocellular carcinoma: a case series investigating histopathologic and clinical characteristics and its potential association with cirrhosis. Am J Clin Pathol Ghandour F, Zein-Sabatto B, Lobo J, Patel C, Dhall D, Manne U, Al Diffalha S. PMID: 42308143 [PubMed - indexed for MEDLINE]
	Risk factors for posthepatectomy liver failure: a secondary analysis of prospective clinical trials. Langenbecks Arch Surg Betzler A, Betzler J, Reissfelder C, Weitz J, Rahbari NN, Birgin E. PMID: 42307778 [PubMed - indexed for MEDLINE]
	Synchronous colorectal liver metastases: short- and long-term outcome analysis of staged versus simultaneous resection. Minerva Surg Stylianidi MC, Vaghiri S, Fedarenka L, Knoefel WT, Kalmuk S, Prassas D. PMID: 42304871 [PubMed - indexed for MEDLINE]
	TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis. Eur Radiol Exp Ding R, Xu XY, Liu RB, Tie J, Duan XH, Xiong B, Yuan DG, Fan WJ, Wang L, Wu ZQ, Zheng J, Zhao H, Hou CL, Song JL, Zhao BS, Zhu XL, Su YJ, Wang S, Yin GW, Chen L, Zhu HD, Teng GJ, Zhong BY, CHANCE2410 Investigators. PMID: 42301580 [PubMed - indexed for MEDLINE]
	Efficacy and safety of local treatments combined with targeted therapy and immunotherapy versus targeted therapy plus immunotherapy alone in hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) Zhang S, Tang Y, Mao X, Sheng T. PMID: 42299577 [PubMed - indexed for MEDLINE]
	A dosimetric analysis of a rotating gamma ray system and volumetric modulated arc therapy in retrospective replanning for primary liver cancer. J Appl Clin Med Phys Zhang J, Shi S, Wu J, Shi L, Song L, Yang M, Yu H, Zhen P, Fang F. PMID: 42298802 [PubMed - indexed for MEDLINE]
	Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma. Front Immunol Wang Z, Tang J, Zhu S, Li S, Yao B, Tu J, Zhou X, Tang Q, Zhong L. PMID: 42292467 [PubMed - indexed for MEDLINE]
	DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study. Front Immunol Ma Y, Long J, Shi S, Fang X, Wang R, Xiong F, Ren H, Li W, Zhang X. PMID: 42292418 [PubMed - indexed for MEDLINE]
	Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study. Front Immunol Lu H, Xu T, Li J, Tang B, Zeng Y, Li X, Cun J, Xia X, Hu J, Xie X, Fan H. PMID: 42292386 [PubMed - indexed for MEDLINE]
	RARE CLINICAL CASE OF CHORIOCARCINOMA WITH MULTIPLE METASTASES AND A FAVORABLE OUTCOME: DIAGNOSTIC CHALLENGES. Georgian Med News Lutvinov S, Malinina O, Taran O, Sorokoumova I, Vozniuk A, Jaruchowska M. PMID: 42289107 [PubMed - indexed for MEDLINE]
	Performance of GPT-based large language models in hepatocellular carcinoma stratification: liver function assessment, BCLC staging, and treatment recommendations. Sci Rep Masthoff M, Zipser A, Praktiknjo M, Trebicka J, Morgül H, Pascher A, Pöhler G, Köhler M, Schindler P. PMID: 42286178 [PubMed - indexed for MEDLINE]
	Dietary Polyphenols and Selected Nutraceuticals in Hepatocellular Carcinoma: Mechanistic Insights, Translational Evidence, and Clinical Prospects. Nutrients Arshad F, Akbar A, Chinnappan R, Khan MI, Yaqinuddin A, Arora I. PMID: 42280426 [PubMed - indexed for MEDLINE]
	Aristolochic Acid and Hepatocellular Carcinoma: A Critical Review of Genotoxic and Inflammatory Mechanisms. Int J Mol Sci Wang Y, Zhang Y, Ren T, Yuan L, Geng X. PMID: 42278277 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76438

Page 1 of 3822



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy